Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.
Journal: Advances in therapy
Published: December 23, 2022
Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.
Journal: Dermatology and therapy
Published: November 16, 2022
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry.
Journal: Dermatology and therapy
Published: September 23, 2022
Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry.
Journal: Dermatology and therapy
Published: July 14, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
Journal: Drug safety
Published: March 19, 2021
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 18, 2019
Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
Journal: Advances in therapy
Published: September 16, 2016
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
Journal: Journal of clinical pharmacology
Published: May 24, 2016
Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study.
Journal: The Journal of urology
Published: December 29, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026